After FTC Commissioners Fired, Marketers Speculate on Future of Industry Regulation
BranchLab CEO, Josh Walsh, weighs in on the role state regulations will play for marketers, especially pharma advertisers, in the vacuum of federal regulation.
20 Ad Tech Executives Predict 2025 Trends
BranchLab’s Michael Parkes predicts: “State privacy regulations, such as Washington’s My Health My Data Act, will profoundly reshape pharmaceutical advertising by imposing strict limitations on the use of health data….
Is Targeted Pharma Advertising Over? Not Quite
BranchLab’s Michael Parkes provides an overview of the emerging state regulations impacting the media strategies of pharmaceutical and healthcare brands, offering recommendations on how to navigate a new era of…
Health and Wellness Brands Brace for Ad Restrictions on Meta
BranchLab CEO, Josh Walsh, weighs in on Meta’s move to implement stricter policies for health and wellness brands.
No More TV Drug Ads? Don’t Hold Your Breath
Does the incoming Trump administration and RFK Jr.’s potential appointment as the head of Health and Human Services (HHS) spell the end of TV drug ads? Probably not, argues Josh Walsh, CEO…
With RFK Headed to HHS, What Should Pharma Advertisers be Thinking About?
President-elect Donald Trump named Robert F. Kennedy Jr. as his pick to run the Department of Health and Human Services (HHS) when he returns to the White House. Kennedy has…
